Literature DB >> 30103077

Advancement of Near-infrared (NIR) laser interceded surface enactment of proline functionalized graphene oxide with silver nanoparticles for proficient antibacterial, antifungal and wound recuperating therapy in nursing care in hospitals.

Xin Wu1, Hui Li2, Ning Xiao3.   

Abstract

Medication obstruction of microscopic organisms has turned into a worldwide medical issue, as it makes the ordinary anti-toxins less effective. It is desperately expected to investigate novel antibacterial materials and create viable treatment techniques to defeat the medication obstruction of anti-infection agents. Herein, we effectively fabricated silver nanoparticles improved proline/graphene oxide nano-flakes (GO-Pro/n-Ag) as novel anti-pathogenic substance through simplistic technique. The property of the silver nanoparticles activated discharge gave amazing antibacterial and antifungal movement against the pathogenic microorganism. Upon supply of NIR, the graphene oxide based biomaterials privately increased the temperature, bringing about the high mortality of pathogenic microorganism. The GO-Pro biocomposite activated n-Ag particles discharging approach for antibacterial, antifungal enables n-Ag to be ensured by proline layout without influencing normal cells. The biocomposites provided antibacterial and antifungal movement against S. aureus, P.aeruginosa, C. albicans and S. cerevisia. Also, the L929 mouse fibroblast cells were utilized for cytocompatibility assessment, and the GO-Pro/n-Ag demonstrated low lethality. Likewise, the GO-Pro/n-Ag and GO-Pro/n-Ag + NIR are set up for in vivo tests and demonstrate incredible antibacterial property in wound model. As the fabricated GO-Pro/n-Ag biocomposite nano-flakes have the benefits of minimal effort and high anti-pathogenic activity, they may be of promising and helpful antibacterial and antifungal specialists for various biomedical applications.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibacterial: Graphene oxide: Silver nanoparticles; NIR treatment; Nursing care; Wound healing

Mesh:

Substances:

Year:  2018        PMID: 30103077     DOI: 10.1016/j.jphotobiol.2018.07.015

Source DB:  PubMed          Journal:  J Photochem Photobiol B        ISSN: 1011-1344            Impact factor:   6.252


  6 in total

1.  Novel antibacterial hydrogels based on gelatin/polyvinyl-alcohol and graphene oxide/silver nanoconjugates: formulation, characterization, and preliminary biocompatibility evaluation.

Authors:  Jorge Luis Patarroyo; Javier Cifuentes; Laura N Muñoz; Juan C Cruz; Luis H Reyes
Journal:  Heliyon       Date:  2022-03-21

2.  In Situ Synthesis of a Silver-Containing Superabsorbent Polymer via a Greener Method Based on Carboxymethyl Celluloses.

Authors:  Jie Shen; Chang Cui; Jian Li; Lijuan Wang
Journal:  Molecules       Date:  2018-09-27       Impact factor: 4.411

3.  Antibacterial activity and mechanism of silver nanoparticles against multidrug-resistant Pseudomonas aeruginosa.

Authors:  Shijing Liao; Yapeng Zhang; Xuanhe Pan; Feizhou Zhu; Congyuan Jiang; Qianqian Liu; Zhongyi Cheng; Gan Dai; Guojun Wu; Linqian Wang; Liyu Chen
Journal:  Int J Nanomedicine       Date:  2019-02-25

4.  Dual bio-active factors with adhesion function modified electrospun fibrous scaffold for skin wound and infections therapeutics.

Authors:  Jianhang Jiao; Chuangang Peng; Chen Li; Zhiping Qi; Jing Zhan; Su Pan
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

5.  Combined carbon photon and hydrogel therapy mediates the synergistic repair of full-thickness skin wounds.

Authors:  Fan Yang; Xiuling Zhou; Sitong Chen; Qiuju Li; Ronghang Li; Chunying Li; Chenyu Shi; Lanyu Zhu
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

6.  Antibacterial Property of Composites of Reduced Graphene Oxide with Nano-Silver and Zinc Oxide Nanoparticles Synthesized Using a Microwave-Assisted Approach.

Authors:  Yi-Huang Hsueh; Chien-Te Hsieh; Shu-Ting Chiu; Ping-Han Tsai; Chia-Ying Liu; Wan-Ju Ke
Journal:  Int J Mol Sci       Date:  2019-10-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.